Treating Redness and Facial Vessels with Lasers
178241782417824rosaceaNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Arisa Ortiz, director of laser and cosmetic dermatology at UC San Diego Health. Dr. Ortiz shares her tips in using lasers to treat rosacea and redness, which are common conditions she sees in her practice. Find out why setting patient expectations is especially important. Learn why looki …
rosacea
Patient Buzz: Stopping Filler | The Expert Weighs In
178031780317803fillerAllure recently posted an article on what happens if a person stops getting filler. What should dermatologists recommend to their patients who want to stop using filler? How can dermatologists help prevent “filler fatigue”? For expert advice, I reached out to Robyn Siperstein, MD, FAAD, a dermatologist in Boca Raton and Boynton Beach, Fla. Have you noticed more of your patients lookin …
filler
A Mindfulness-Based Smartphone Application Intervention to Improve the Quality of Life of Patients with CTCL
177271772717727CTCLDr. Nishad Sathe, Next Steps Correspondent, interviewed Lily M. Parker, second year medical student at the University of South Florida Morsani College of Medicine, to dig deeper on her research study titled “A mindfulness-based smartphone application intervention to improve the quality of life of patients with cutaneous T-cell lymphoma. A pilot/feasibility study, and an analysis of social determ …
CTCL
Best Practices & What to Avoid During Culturally Sensitive Derm Consults
177961779617796skin of colorNext Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Candrice Heath, assistant professor of dermatology at the Lewis Katz School of Medicine at Temple University. Dr. Heath shares her tips for culturally sensitive dermatology consults, specifically consults involving hair concerns in children. Watch as she encourages clinicians to consider time when creating a treatment p …
skin of color
Roflumilast Therapeutic Cheat Sheet
177781777817778RoflumilastRoflumilast is a non-steroidal topical cream that was FDA approved for the treatment of plaque psoriasis in 2022.1 Roflumilast selectively inhibits phosphodiesterase-4 (PDE-4), which is an enzyme that mediates inflammatory responses and has been shown to play a role in several dermatologic diseases.2 Prior to topical roflumilast, oral PDE-4 inhibitors have been investigated across a wide variety o …
Roflumilast